From: Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial
non-POC group
POC group
Wilcoxon test
mean
median
IQR
p-value
MV (hours)
147.8
35.5
50.5
90.3
25
36
0.17
ICU stay (days)
13
6
3.3
9.5
5
4
0.27